Incorporated in 2005, Laurus Labs Ltd is Hyderabad based pharmaceutical company. Laurus Labs is in the business of manufacturing generic active pharmaceutical ingredients (APIs) for therapeutic areas of antiretrovirals (ARVs) and Hepatitis C. Company also manufacture APIs in oncology and other therapeutic areas.
Laurus Labs operates in four business lines:
1. Generics active pharmaceutical ingredients (APIs) - The development, manufacture and sale of APIs and advanced intermediates.
2. Generics finished dosage forms (FDFs) - The development and manufacture of oral solid formulations.
3. Synthesis - Contract development and manufacturing services for global pharmaceutical companies.
4. Ingredients - The manufacture and sale of specialty ingredients for use in the nutraceutical and cosmeceutical sectors.
Key Highlights:
1. Laurus Labs launched 59 products since our inception in 2005.
2. Nine out of the 10 largest generic pharmaceutical companies in the world are its customers.
3. Laurus Labs employed 587 scientists at our R&D center in Hyderabad and 12 scientists at R&D centre in Greater Boston USA.
4. The Company owned 32 patents and had 150 pending patent applications, in several countries.
5. Company has three manufacturing facilities in Visakhapatnam, Andhra Pradesh.
6. Company sells its products in 32 countries in Sub-Saharan Africa, South-East Asia and Latin America.
Key Strengths:
1. Leadership in APIs in Select, High Growth Therapeutic Areas
2. Strong R&D Capabilities and Process Chemistry Skills
3. Industry Leading, Modern and Regulatory Compliant Manufacturing Capacities
4. Long-standing Relationships with Multi-National Pharmaceutical Companies
5. Experienced Promoters and Qualified Operational Personnel
6. Established Track Record of Delivering Growth
The Promoters of the company are:
1. Dr Satyanarayana Chava
2. Naga Rani Chava
3. Dr Raju Srihari Kalidindi
4. Ravi Kumar V V and
5. Dr Lakshmana Rao C V
Particulars | For the year/period ended (in Rs. Million) | ||||
---|---|---|---|---|---|
31-Mar-16 | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | 31-Mar-12 | |
Total Assets | 23,083.48 | 18,925.49 | 12,730.58 | 7,009.89 | 5,128.78 |
Total Revenue | 17,884.15 | 13,603.80 | 11,685.34 | 7,235.67 | 4,523.07 |
Profit After Tax (PAT) | 1,435.68 | 735.17 | 972.17 | 882.19 | 215.77 |
The object of the issue are to:
1. Pre-payment of term loans; and
2. General corporate purposes.
IPO Opening Date | Dec 6, 2016 |
IPO Closing Date | Dec 8, 2016 |
Issue Type | Book Built Issue IPO |
Face Value | ₹10 per equity share |
IPO Price | ₹426 to ₹428 per equity share |
Market Lot | 35 Shares |
Min Order Quantity | 35 Shares |
Listing At | BSE, NSE |
Issue Size | 31,116,785 Eq Shares of ₹10 (aggregating up to ₹1,331.80 Cr) |
Fresh Issue | 7,009,345 Eq Shares of ₹10 (aggregating up to ₹300.00 Cr) |
Offer for Sale | 24,107,440 Eq Shares of ₹10 (aggregating up to ₹1,031.80 Cr) |
The Laurus Labs IPO open date is Dec 6, 2016, and the close date is Dec 8, 2016. The issue may list on Dec 19, 2016.
IPO Open Date | Dec 6, 2016 |
IPO Close Date | Dec 8, 2016 |
Basis of Allotment Date | Dec 14, 2016 |
Initiation of Refunds | Dec 15, 2016 |
Credit of Shares to Demat Account | Dec 16, 2016 |
IPO Listing Date | Dec 19, 2016 |
The Laurus Labs IPO market lot size is 35 shares. A retail-individual investor can apply for up to 13 lots (455 shares or ₹194,740).
Application | Lots | Shares | Amount (Cut-off) |
---|---|---|---|
Minimum | 1 | 35 | ₹14,980 |
Maximum | 13 | 455 | ₹194,740 |
The Laurus Labs IPO is subscribed 4.53x times on Dec 8, 2016 18:18. The public issue subscribed 1.58x in the retail category, 10.54x in the QIB category, and 3.57x in the NII category. Check Day by Day Subscription Details (Live Status)
Category | IPO Subscription |
---|---|
QIB | 10.54x |
NII | 3.57x |
RII | 1.58x |
Employee | 1.71x |
Total | 4.53x |
Listing Date | Monday, December 19, 2016 |
BSE Script Code | 540222 |
NSE Symbol | LAURUSLABS |
Listing In | B |
ISIN | INE947Q01010 |
IPO Price | ₹428 per equity share |
Face Value | ₹10 per equity share |
|
|
|
Laurus Labs Ltd
Plot No.21,
Jawaharlal Nehru Pharma City,
Parawada, Visakhapatnam 531 021
Phone: + 91 40 3980 4333
Email: secretarial@lauruslabs.com
Website: http://www.lauruslabs.com
KFintech Private Limited
Selenium Building, Tower-B, Plot No 31 & 32,
Financial District,Nanakramguda, Serilingampally,
Rangareddi, Telangana India - 500 032.
Phone: 1-800-3454001
Email: einward.ris@karvy.com
Website: https://karisma.kfintech.com/
Laurus Labs IPO is a main-board IPO of 31,116,785 equity shares of the face value of ₹10 aggregating up to ₹1,331.80 Crores. The issue is priced at ₹426 to ₹428 per equity share. The minimum order quantity is 35 Shares.
The IPO opens on Dec 6, 2016, and closes on Dec 8, 2016.
KFintech Private Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Laurus Labs IPO opens on Dec 6, 2016 and closes on Dec 8, 2016.
Laurus Labs IPO lot size is 35 Shares and the minimum order quantity is 35 Shares.
You can apply in Laurus Labs IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Laurus Labs IPO will be done on Dec 14, 2016, and the allotted shares will be credited to your demat account by Dec 16, 2016. Check the Laurus Labs IPO allotment status.
Useful Articles
Best of
Top Stock Brokers in India Top 10 Discount Brokers Top 10 Full-Service Brokers Lifetime Free Demat Account Best Broker for Beginners More Reports...Reviews (Discount Broker)
Zerodha (₹20/trade) Edelweiss (₹10/trade) Upstox (₹20/trade) 5paisa (₹20/trade) ProStocks (₹899 Unlimited) More Brokers...Reviews (Full-service)
ICICI Direct Motilal Oswal HDFC Sec Sharekhan IIFL Securities More Brokers...Compare Brokers
Broker Articles / Tutorials Compare Share Brokers Side-by-Side Comparison Broker Complaints Monitor Broker Glossary Special OffersTrading Platform Reviews
Zerodha Kite Review Sharekhan TradeTiger Omnesys NEST Review ODIN Review NSE NOW Review More Reviews...Options Basics
Options Trading HomepageBroker Reviews
Zerodha Review 5paisa Review ProStocks Review Sharekhan Review Angel Broking Review ICICI DirectOptions Trading Platform
Kite Zerodha Trade Tiger Sharekhan Omnisys NEST Upstox RKSV Fyers One Fyers ScalperT FinvasiaBest of
NRI HomepageNRI Trading Guide
Trading Account Basics Trading Requirements Demat Account Explained USA NRI Trading Account Trading in Derivatives More Articles...History of Chittorgarh
History of Chittorgarh Maharana Pratap Meera Bai Panna Dhai Rani Padmini Jainism & Chittor (Hindi)Chittorgarh City Info
Chittorgarh City Map Hotels / Resorts Sainik School Chittorgarh Cement Industry Hindustan Zinc